IDDF2024-ABS-0066 Novel peptides derived from sutterella wadsworthensis potentiating the efficacy of PD-1 blockade on colorectal cancer
<h3>Background</h3> Blockade of the PD-1/L1 axis has emerged as an effective treatment for various cancers, resulting in remarkable clinical efficacy, but most patients have no response. Gut microbiota is a critical factor in determining the efficacy of PD-1/L1 blockade. We aimed to explore the role and mechanism of <i>Sutterella wadsworthensis (S.wadsworthensis)</i> in improving the responsiveness of anti-PD-1 immunotherapy. <h3>Methods</h3> The effects of <i>S.wadsworthensis</i> on PD-1 blockade efficacy were evaluated in murine models of colorectal cancer. Flow cytometry was performed to evaluate the anti-tumor immunity. RNA sequencing (RNA-seq) and peptidomics were used to identify potential immunomodulatory pathways and peptides, respectively. <h3>Results</h3> We first reported that live <i>S.wadsworthensis</i> supplementation remarkably improved anti-PD-1 efficacy in the MC38 and CT26 murine model, with increased tumor-infiltrating CD4<sup>+</sup>ICOS<sup>+</sup> T cells, and activated Th1 (CD4<sup>+</sup>IFN-γ<sup>+</sup>TNF-α<sup>+</sup>) and cytotoxic T cells (CD8<sup>+</sup>IFN-γ<sup>+</sup>TNF-α<sup>+</sup>) response. Colonic RNA-seq results showed that <i>S.wadsworthensis</i> up-regulated the expression of genes related to major histocompatibility complex II (MHC-II), and induced the enrichment of antigen processing and presentation signals. Moreover, tumor RNA-seq results suggested that enhanced T cell receptor (TCR) signal mediated by MHC-II restricted antigen presentation process was required for the activation of T cell response in the combination of <i>S.wadsworthensis</i> and PD-1 mAb, as evidenced by abolished synergistic effect after the specific block of MHC-II signal. Furthermore, two peptides stably bound to MHC-II were identified from <i>S.wadsworthensis</i>, which enhanced the killing activity of mouse splenocytes against MC38 cells <i>in vitro</i> and augmented the antitumour activity of PD-1 mAb in vivo by increasing CD4<sup>+</sup>IFN-γ<sup>+</sup> and CD8<sup>+</sup>IFN-γ<sup>+</sup> T cells. <h3>Conclusions</h3> Our study showed that <i>S.wadsworthensis</i> and <i>S.wadsworthensis</i>-derived peptides induced the crosstalk between the gut and distal tumor via the MHC-II/TCR-ICOS signal to remodel anti-tumor immunity, achieving synergistic effect with PD-1 mAb. <i>S.wadsworthensis</i> and <i>S.wadsworthensis</i>-derived peptides may serve as potential adjuvants to enhance PD-1 mAb efficacy.
Authors
- Yongchao Gao (ORCID: https://orcid.org/0000-0002-1631-7390)
- Dingding Zhou
- Weihua Huang (ORCID: https://orcid.org/0000-0003-4167-8304)
- Rong Liu (ORCID: https://orcid.org/0000-0001-5170-6474)
- Wei Zhang (ORCID: https://orcid.org/0000-0003-2097-6089)
Institutions
- Central South University (CN)
- Xiangya Hospital Central South University (CN)
Publication Details
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1136/gutjnl-2024-iddf.54
- Citations
- 1
- Primary Topic
- Cancer, Stress, Anesthesia, and Immune Response
- Type
- article
- Field-Weighted Citation Impact
- 0.39